Trialbee recently appointed Rick Riegel to its Board of Directors. Currently, the company leads the industry in technology-driven global patient recruitment. Riegel brings over 30 years of leadership in life sciences. His expertise focuses on growth and operational transformation. Consequently, this move reinforces the company’s commitment to strategic expansion.
Riegel currently leads LMC Advisory, LLC. Previously, he served as CEO for Phlexglobal and LIQUENT. He also held leadership roles at IBM and First Consulting Group. Therefore, his background includes scaling high-growth technology firms. Trialbee expects him to strengthen its enterprise partnerships worldwide.
Strengthening Global Clinical Partnerships
Furthermore, Trialbee uses a data-driven approach to identify patients. The platform features advanced embedded AI capabilities. Recent investment from Varsity Healthcare Partners supports this continued growth. Riegel will help the management team reach new performance standards. This partnership ensures efficient global patient recruitment outcomes for sponsors.
Additionally, Riegel serves on boards for several private equity organizations. His skills cover commercial strategy and global scale. He has acted as a trusted mentor to the Trialbee leadership. Now, he joins the board to support the next expansion phase. Trialbee continues to redefine global patient recruitment benchmarks across the industry.
“Rick has consistently demonstrated an ability to scale organizations, sharpen strategic focus, and deliver measurable impact for customers-expertise that will be critical as Trialbee furthers our mission of redefining Global Patient Recruitment and improving enrollment outcomes,” said Matt Walz, CEO of Trialbee. “On a personal note, Rick has been a trusted mentor of mine and Advisory Board member since I joined Trialbee. I’m grateful to have him join our Board of Directors, working alongside our management team for this next phase of growth.”
“Under Matt’s leadership as CEO, Trialbee has established itself as a defining force in reshaping how sponsors and CROs identify, recruit, and engage patients globally,” said Riegel. The company’s data-driven approach, embedded AI capabilities, and expanding global footprint are delivering measurable impact across the industry and setting a new standard for performance. The recent investment from Varsity Healthcare Partners reflects the strength of that progress and positions Trialbee to scale its platform and partnerships even further. I’m excited to support the leadership team as the company builds on this momentum and accelerates its next phase of growth.”
Explore Health Tech Insiders for the latest medical innovations and reliable strategic insights driving the future of technology-driven healthcare transformation.
News Source: Businesswire.com
